In most regions of the world, antimicrobial resistance has increased to the point where
empirical standard triple therapy for Helicobacter pylori eradication is no longer …

Background As with any other infectious disease, we should aim for treatments offering≥
90% Helicobacter pylori eradication rates in clinical practice. Aim To summarize optimization …

Background & Aims Due to the poor eradication rates of standard triple therapy, the addition
of bismuth salts has been proposed for first-line eradication of Helicobacter pylori. We …

The occurrence of refractory Helicobacter pylori infection is increasing. When the bacteria
are not eradicated it means that the antibiotics have not reached the gastric mucosa at a …

Abstract Background: Management of Helicobacter pylori, a causative agent of
gastrointestinal diseases is an important health problem in most countries. The main …

Background: Triple therapy (proton pump inhibitor, clarithromycin and amoxicillin or an
imidazole) is the first‐line treatment for Helicobacter pylori infection. However, the …

Background: High-dose dual therapy (HDDT) with proton pump inhibitors (PPIs) and
amoxicillin has attracted widespread attention due to its favorable efficacy in eradicating …

Antibiotic resistance is a major cause of Helicobacter pylori (H. pylori) treatment failures.
Because the resistance rate of H. pylori to furazolidone is low, we aimed to assess the …

Background: Helicobacter pylori infection may persist after both first‐and second‐line
current treatments. Aim: To assess the efficacy of a third‐line, culture‐guided treatment …

Background: Helicobacter pylori (H. pylori) infection is known as a major etiologic factor for a
variety of gastroduodenal diseases. In Iran, with a high rate of H. pylori infection close to …